Enhanced recovery after surgery is feasible and safe in liver transplantation: a cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Enhanced recovery after surgery is feasible and safe in liver transplantation : a cohort study. / Hillingsø, Jens G.; Rostved, Andreas A.; Dengsø, Kristine E.; Sørensen, Carina L.; Frederiksen, Hans J.; Krohn, Paul S.; Petersen, Christian R.; Larsen, Peter N.; Fukumori, Daisuke; Burgdorff, Stefan K.; Kehlet, Henrik; Schultz, Nicolai A.

In: HPB, Vol. 24, No. 11, 2022, p. 2022-2028.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hillingsø, JG, Rostved, AA, Dengsø, KE, Sørensen, CL, Frederiksen, HJ, Krohn, PS, Petersen, CR, Larsen, PN, Fukumori, D, Burgdorff, SK, Kehlet, H & Schultz, NA 2022, 'Enhanced recovery after surgery is feasible and safe in liver transplantation: a cohort study', HPB, vol. 24, no. 11, pp. 2022-2028. https://doi.org/10.1016/j.hpb.2022.07.010

APA

Hillingsø, J. G., Rostved, A. A., Dengsø, K. E., Sørensen, C. L., Frederiksen, H. J., Krohn, P. S., Petersen, C. R., Larsen, P. N., Fukumori, D., Burgdorff, S. K., Kehlet, H., & Schultz, N. A. (2022). Enhanced recovery after surgery is feasible and safe in liver transplantation: a cohort study. HPB, 24(11), 2022-2028. https://doi.org/10.1016/j.hpb.2022.07.010

Vancouver

Hillingsø JG, Rostved AA, Dengsø KE, Sørensen CL, Frederiksen HJ, Krohn PS et al. Enhanced recovery after surgery is feasible and safe in liver transplantation: a cohort study. HPB. 2022;24(11):2022-2028. https://doi.org/10.1016/j.hpb.2022.07.010

Author

Hillingsø, Jens G. ; Rostved, Andreas A. ; Dengsø, Kristine E. ; Sørensen, Carina L. ; Frederiksen, Hans J. ; Krohn, Paul S. ; Petersen, Christian R. ; Larsen, Peter N. ; Fukumori, Daisuke ; Burgdorff, Stefan K. ; Kehlet, Henrik ; Schultz, Nicolai A. / Enhanced recovery after surgery is feasible and safe in liver transplantation : a cohort study. In: HPB. 2022 ; Vol. 24, No. 11. pp. 2022-2028.

Bibtex

@article{e89e086af5c9415bb877322a84dd7c89,
title = "Enhanced recovery after surgery is feasible and safe in liver transplantation: a cohort study",
abstract = "Background: The principles of enhanced recovery after surgery (ERAS) are being applied to still more advanced procedures. Liver transplantation offers a unique opportunity for a multimodal approach including donor care as well. Our objective was to determine if ERAS was applicable and safe in orthotopic liver transplantation (OLT). Methods: A national single centre retrospective study showing the implementation of ERAS from 2013 to 2019 with the proceeding 2 years serving as baseline. The primary endpoints were mortality, length of stay (LOS) in the ward and intensive care unit stay. Secondary endpoints were complications estimated by Dindo-Clavien classification, comprehensive complication index (CCI{\textregistered}) and re-admissions. Results: A total of 334 patients were included. LOS was significantly reduced from a median of 22.5 days at introduction to 14 days at 2019. Cold ischaemia time was reduced from a mean of 10.7 to 6.0 h and the use of blood products (erythrocytes, plasma and thrombocytes) from a median of 28 to 6 units. Complications were reduced in severity. Mortality and readmission rates were not affected. Conclusion: ERAS principles are safe and recommended in patients undergoing OLT resulting in reduced severity of complications and LOS without affecting re-admissions or mortality.",
author = "Hillings{\o}, {Jens G.} and Rostved, {Andreas A.} and Dengs{\o}, {Kristine E.} and S{\o}rensen, {Carina L.} and Frederiksen, {Hans J.} and Krohn, {Paul S.} and Petersen, {Christian R.} and Larsen, {Peter N.} and Daisuke Fukumori and Burgdorff, {Stefan K.} and Henrik Kehlet and Schultz, {Nicolai A.}",
note = "Publisher Copyright: {\textcopyright} 2022 International Hepato-Pancreato-Biliary Association Inc.",
year = "2022",
doi = "10.1016/j.hpb.2022.07.010",
language = "English",
volume = "24",
pages = "2022--2028",
journal = "HPB",
issn = "1365-182X",
publisher = "Elsevier",
number = "11",

}

RIS

TY - JOUR

T1 - Enhanced recovery after surgery is feasible and safe in liver transplantation

T2 - a cohort study

AU - Hillingsø, Jens G.

AU - Rostved, Andreas A.

AU - Dengsø, Kristine E.

AU - Sørensen, Carina L.

AU - Frederiksen, Hans J.

AU - Krohn, Paul S.

AU - Petersen, Christian R.

AU - Larsen, Peter N.

AU - Fukumori, Daisuke

AU - Burgdorff, Stefan K.

AU - Kehlet, Henrik

AU - Schultz, Nicolai A.

N1 - Publisher Copyright: © 2022 International Hepato-Pancreato-Biliary Association Inc.

PY - 2022

Y1 - 2022

N2 - Background: The principles of enhanced recovery after surgery (ERAS) are being applied to still more advanced procedures. Liver transplantation offers a unique opportunity for a multimodal approach including donor care as well. Our objective was to determine if ERAS was applicable and safe in orthotopic liver transplantation (OLT). Methods: A national single centre retrospective study showing the implementation of ERAS from 2013 to 2019 with the proceeding 2 years serving as baseline. The primary endpoints were mortality, length of stay (LOS) in the ward and intensive care unit stay. Secondary endpoints were complications estimated by Dindo-Clavien classification, comprehensive complication index (CCI®) and re-admissions. Results: A total of 334 patients were included. LOS was significantly reduced from a median of 22.5 days at introduction to 14 days at 2019. Cold ischaemia time was reduced from a mean of 10.7 to 6.0 h and the use of blood products (erythrocytes, plasma and thrombocytes) from a median of 28 to 6 units. Complications were reduced in severity. Mortality and readmission rates were not affected. Conclusion: ERAS principles are safe and recommended in patients undergoing OLT resulting in reduced severity of complications and LOS without affecting re-admissions or mortality.

AB - Background: The principles of enhanced recovery after surgery (ERAS) are being applied to still more advanced procedures. Liver transplantation offers a unique opportunity for a multimodal approach including donor care as well. Our objective was to determine if ERAS was applicable and safe in orthotopic liver transplantation (OLT). Methods: A national single centre retrospective study showing the implementation of ERAS from 2013 to 2019 with the proceeding 2 years serving as baseline. The primary endpoints were mortality, length of stay (LOS) in the ward and intensive care unit stay. Secondary endpoints were complications estimated by Dindo-Clavien classification, comprehensive complication index (CCI®) and re-admissions. Results: A total of 334 patients were included. LOS was significantly reduced from a median of 22.5 days at introduction to 14 days at 2019. Cold ischaemia time was reduced from a mean of 10.7 to 6.0 h and the use of blood products (erythrocytes, plasma and thrombocytes) from a median of 28 to 6 units. Complications were reduced in severity. Mortality and readmission rates were not affected. Conclusion: ERAS principles are safe and recommended in patients undergoing OLT resulting in reduced severity of complications and LOS without affecting re-admissions or mortality.

U2 - 10.1016/j.hpb.2022.07.010

DO - 10.1016/j.hpb.2022.07.010

M3 - Journal article

C2 - 35973930

AN - SCOPUS:85136763079

VL - 24

SP - 2022

EP - 2028

JO - HPB

JF - HPB

SN - 1365-182X

IS - 11

ER -

ID: 329434696